|
|
|
|
Postvaccination meningoencephalitis occurred without clear relation to serum anti-AB42 antibody titers. Potential mechanisms such as T-cell and microglial activation may be responsible and are under consideration to develop a safer anti-AB immunotherapy for AD. |
|